Avesthagen Limited,a leading Indian biotechnology firm, has entered into stategic alliance with Uxmal S.A., a Chilean biotechnology firm for promoting research and development of bioactives for commercialisation and use in products like functional foods and healthcare.
Avesthagen also announced its international expansion by setting up Avesthagen Latam SpA at the Venture Lab at the Business School of the Universidad Adolfo Ibanez in Penanlolen, Santiago.
The two firms would work on bioactives and tissue culture for development of bioinformatic platforms based on Latin American plants, development and commercialisation of functional foods based on bioactives developed by Avestahgen and those from Latin American medicinal plants.
It would also work on development of bioactives and tissue culture of a specific plant species for commercial applications and production of bioactives globally. The firms would work on marketing of biosimilars that are in an advanced stage of development at Avesthagen.
According Dr Villoo Moarawala Patel, CMD, Avesthagen "We intend to use our domain expertise and knowledge base in furthering research and development related activities for the development of technology and products in agriculture, pharma and food business internationally."
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
